NEVPF
Price
$0.03
Change
-$0.00 (-0.00%)
Updated
Jan 23 closing price
Capitalization
45.13M
TNXP
Price
$17.02
Change
+$2.06 (+13.77%)
Updated
Apr 23 closing price
Capitalization
102.89M
18 days until earnings call
Ad is loading...

NEVPF vs TNXP

Header iconNEVPF vs TNXP Comparison
Open Charts NEVPF vs TNXPBanner chart's image
Abliva AB
Price$0.03
Change-$0.00 (-0.00%)
Volume$58.9K
Capitalization45.13M
Tonix Pharmaceuticals Holding
Price$17.02
Change+$2.06 (+13.77%)
Volume$853.82K
Capitalization102.89M
NEVPF vs TNXP Comparison Chart
Loading...
TNXP
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
View a ticker or compare two or three
VS
NEVPF vs. TNXP commentary
Apr 24, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is NEVPF is a Hold and TNXP is a Hold.

Ad is loading...
COMPARISON
Comparison
Apr 24, 2025
Stock price -- (NEVPF: $0.03 vs. TNXP: $16.95)
Brand notoriety: NEVPF and TNXP are both not notable
Both companies represent the Biotechnology industry
Current volume relative to the 65-day Moving Average: NEVPF: 100% vs. TNXP: 50%
Market capitalization -- NEVPF: $45.13M vs. TNXP: $102.89M
NEVPF [@Biotechnology] is valued at $45.13M. TNXP’s [@Biotechnology] market capitalization is $102.89M. The market cap for tickers in the [@Biotechnology] industry ranges from $266.85B to $0. The average market capitalization across the [@Biotechnology] industry is $2.09B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

NEVPF’s FA Score shows that 0 FA rating(s) are green whileTNXP’s FA Score has 1 green FA rating(s).

  • NEVPF’s FA Score: 0 green, 5 red.
  • TNXP’s FA Score: 1 green, 4 red.
According to our system of comparison, both NEVPF and TNXP are a bad buy in the long-term.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

TNXP’s TA Score shows that 5 TA indicator(s) are bullish.

  • TNXP’s TA Score: 5 bullish, 5 bearish.

Price Growth

NEVPF (@Biotechnology) experienced а 0.00% price change this week, while TNXP (@Biotechnology) price change was +6.87% for the same time period.

The average weekly price growth across all stocks in the @Biotechnology industry was +8.04%. For the same industry, the average monthly price growth was -8.89%, and the average quarterly price growth was -12.57%.

Reported Earning Dates

TNXP is expected to report earnings on Aug 11, 2025.

Industries' Descriptions

@Biotechnology (+8.04% weekly)

Biotechnology involves genetic or protein engineering to produce medicines/therapies for treating and preventing ailments. The industry also provides crucial ingredients for diagnostics. This multi-billion-dollar industry is heavily focused on research and development, as companies attempt to continually come up with cutting-edge solutions for health. New discoveries for the treatment of diseases provide opportunities for growth for a company in this industry. Discoveries, however, must pass the regulatory approval from the U.S. Food and Drug Administration (FDA) before they can make it to markets. Amgen Inc., Gilead Sciences, Inc. and Celgene Corporation are examples of companies in this industry.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
TNXP($103M) has a higher market cap than NEVPF($45.1M). NEVPF YTD gains are higher at: -22.222 vs. TNXP (-48.605). TNXP has higher annual earnings (EBITDA): -76.74M vs. NEVPF (-87.99M). TNXP has more cash in the bank: 55M vs. NEVPF (32.7M). TNXP has higher revenues than NEVPF: TNXP (11.3M) vs NEVPF (0).
NEVPFTNXPNEVPF / TNXP
Capitalization45.1M103M44%
EBITDA-87.99M-76.74M115%
Gain YTD-22.222-48.60546%
P/E RatioN/AN/A-
Revenue011.3M-
Total Cash32.7M55M59%
Total DebtN/A8.69M-
FUNDAMENTALS RATINGS
NEVPF vs TNXP: Fundamental Ratings
NEVPF
TNXP
OUTLOOK RATING
1..100
4369
VALUATION
overvalued / fair valued / undervalued
1..100
90
Overvalued
17
Undervalued
PROFIT vs RISK RATING
1..100
100100
SMR RATING
1..100
9696
PRICE GROWTH RATING
1..100
3594
P/E GROWTH RATING
1..100
100100
SEASONALITY SCORE
1..100
n/an/a

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

TNXP's Valuation (17) in the Pharmaceuticals Other industry is significantly better than the same rating for NEVPF (90) in the null industry. This means that TNXP’s stock grew significantly faster than NEVPF’s over the last 12 months.

TNXP's Profit vs Risk Rating (100) in the Pharmaceuticals Other industry is in the same range as NEVPF (100) in the null industry. This means that TNXP’s stock grew similarly to NEVPF’s over the last 12 months.

TNXP's SMR Rating (96) in the Pharmaceuticals Other industry is in the same range as NEVPF (96) in the null industry. This means that TNXP’s stock grew similarly to NEVPF’s over the last 12 months.

NEVPF's Price Growth Rating (35) in the null industry is somewhat better than the same rating for TNXP (94) in the Pharmaceuticals Other industry. This means that NEVPF’s stock grew somewhat faster than TNXP’s over the last 12 months.

NEVPF's P/E Growth Rating (100) in the null industry is in the same range as TNXP (100) in the Pharmaceuticals Other industry. This means that NEVPF’s stock grew similarly to TNXP’s over the last 12 months.

TECHNICAL ANALYSIS
Technical Analysis
TNXP
RSI
ODDS (%)
Bearish Trend 1 day ago
90%
Stochastic
ODDS (%)
Bullish Trend 1 day ago
82%
Momentum
ODDS (%)
Bearish Trend 1 day ago
90%
MACD
ODDS (%)
Bearish Trend 1 day ago
90%
TrendWeek
ODDS (%)
Bearish Trend 1 day ago
90%
TrendMonth
ODDS (%)
Bearish Trend 1 day ago
90%
Advances
ODDS (%)
Bullish Trend 17 days ago
79%
Declines
ODDS (%)
Bearish Trend 4 days ago
90%
BollingerBands
ODDS (%)
Bearish Trend 1 day ago
90%
Aroon
ODDS (%)
Bullish Trend 1 day ago
70%
View a ticker or compare two or three
Ad is loading...
TNXP
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
PMETF1.700.10
+6.44%
PATRIOT BATTERY METALS INC
NTIOF84.730.22
+0.26%
National Bank of Canada
IEGCF0.11N/A
+0.09%
Independence Gold Corp.
BTAFF42.00-0.23
-0.54%
British American Tobacco p.l.c.
WJRYY21.86-0.64
-2.84%
West Japan Railway Co.

NEVPF and

Correlation & Price change

A.I.dvisor indicates that over the last year, NEVPF has been loosely correlated with TNXP. These tickers have moved in lockstep 37% of the time. This A.I.-generated data suggests there is some statistical probability that if NEVPF jumps, then TNXP could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To NEVPF
1D Price
Change %
NEVPF100%
N/A
TNXP - NEVPF
37%
Loosely correlated
+13.30%
VRDN - NEVPF
27%
Poorly correlated
-1.82%
SGMT - NEVPF
25%
Poorly correlated
+9.02%
EWTX - NEVPF
22%
Poorly correlated
+9.61%
SNTI - NEVPF
21%
Poorly correlated
+9.65%
More